On the basis of molecular modelling studies the structural and conform
ational requirements for receptor affinity and activity of histamine H
-3-receptor agonists were studied. It was shown that the known H-3-rec
eptor agonists can be fitted accurately into a common pharmacophoric p
attern. Using the YAK pseudoreceptor approach an amino acid model for
the H-3-receptor agonist binding site was generated which reflects bin
ding properties and biological data of the investigated agonists. The
postulated binding site model was validated by predicting biological d
ata for four structures not considered in model construction. The amin
o acid positions of the pseudoreceptor were found to be in good agreem
ent with calculated GRID interaction fields for the investigated hista
mine H-3-receptor agonists.